Refine by
Cancer Monitoring Articles & Analysis
16 articles found
A single missing fucose residue can enhance antibody-dependent cellular cytotoxicity by 50-fold, revolutionizing cancer immunotherapy approaches. The analytical challenge is immense. ...
Versatile Applications: This panel can be applied in various research settings, including cancer immunology, autoimmune diseases, infectious diseases, and neuroinflammation. ...
Alfa Cytology has launched ovarian cancer therapy development services. Alfa Cytology, a prominent services provider in oncology, has launched its cutting-edge ovarian cancer therapy development services. ...
As a result, lipidomic profiling of exosomes holds potential as a diagnostic tool for detecting cancer and monitoring treatment response. Moreover, lipidomic shifts can also reveal insights into metabolic conditions such as obesity, diabetes, and neurodegenerative diseases. ...
The emergence of chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of certain cancers, providing a promising targeted approach to eliminate cancer cells. However, the monitoring and detection of CAR-T cells in vivo remain a challenge in the evaluation of treatment efficacy. ...
Cancer is a complex disease that involves a delicate interplay between the tumor cells and the host immune system. ...
Cancer is a complex disease that involves a delicate interplay between the tumor cells and the host immune system. ...
Introduction Genomics has revolutionized cancer research, transforming the way we diagnose, treat, and monitor cancer. ...
Tumors and Blood Vessel Growth Tumor, as an abnormal mass of cells, has blood vessels of various sizes that can be seen everywhere on the surface and deep within it. Nutrients for life are continuously supplied to the depths of tumor cells through these blood vessels. As the tumor continues to grow, nearby blood vessels also undergo rapid and chaotic growth, with these newly formed capillaries ...
Enzymes that are specific to the disease itself are often used to diagnose and monitor cancer, heart disease, and liver disease. For example, prostate-specific antigen (PSA) is an enzyme that is produced by the prostate gland and is used to diagnose and monitor prostate cancer. Elevated levels of PSA in the blood can indicate the ...
ELISA is commonly used to diagnose infectious diseases, autoimmune disorders, and even cancer. Another enzyme-based diagnostic tool is polymerase chain reaction (PCR), which can detect and amplify small amounts of DNA or RNA in a patient's sample. ...
INOVIQ (IIQ) signs a contract research agreement with Nicoya Lifesciences to develop a SubB2M-based test that uses its Alto digital surface plasmon resonance (SPR) platform The company believes a SubB2M-based SPR test has the potential to be developed as a multi-cancer detection test that first detects the Neu5Gc cancer signal Under the agreement, INOVIQ ...
A preliminary 142-patient study with ClarityDX Bladder showed that it could accurately identify patients with bladder cancer compared to healthy individuals. “We are excited to launch our bladder cancer study and thank all the patients for their generous participation in the study” Tweet this Bladder cancer is the fifth most ...
Multiple myeloma is an essentially incurable plasma cell cancer with a very poor prognosis for patients; however, in a recent study published in Science Translational Medicine entitled "Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the protein CD98 heavy chain," scientists from Osaka University in Japan have discovered the CD98 heavy chain, a common ...
The study, called the Vaccination Against Canine Cancer Study, or VACCS, is the largest, most expensive interventional veterinary cancer trial to date. ...
ByCalviri
Remote patient reported outcomes monitoring systems have been developed for use in cancer treatment, showing benefits in economic and survival outcomes. ...